The Role of Breast Cancer Chemoprevention in High-Risk Women
Some hormone-blocking medicines can lower the chance of certain breast cancers in people whose expected benefit outweighs the risks.
The key things to know
- Preventive endocrine treatment is not chemotherapy.
- Benefit depends on the person's starting risk.
- Side effects and pregnancy plans must be discussed.
What chemoprevention means
In this setting, chemoprevention means using medicine to reduce the chance that breast cancer will develop. It is not the same as chemotherapy for an existing cancer. Tamoxifen and, after menopause, other endocrine medicines may be considered for selected higher-risk people. These medicines mainly reduce estrogen-receptor-positive cancer risk; they do not prevent all breast cancer subtypes.
Who may benefit
A specialist considers age, menopausal status, previous atypical breast biopsies, family history, and estimated risk. The important comparison is the absolute number of cancers potentially avoided against the absolute chance of side effects. Two people with the same relative risk reduction may have very different practical benefits because their starting risks differ. Availability and licensed indications also vary by country.
Balancing unwanted effects
Possible effects include hot flushes and changes in wellbeing. Some medicines can raise blood-clot risk or affect the womb; others can cause joint symptoms and bone loss. A history of clots, pregnancy plans, and other medicines can change what is suitable. Your clinician should explain the particular drug's risks and monitoring, rather than treating all preventive endocrine medicines as interchangeable.
An informed, supported choice
Do not buy or start preventive medication without a clinician-led risk assessment. Ask about the expected duration, follow-up, contraception where relevant, and what symptoms need urgent advice. Lifestyle measures and screening still matter while taking medication. If side effects occur, contact the prescriber: the plan can be reviewed, and declining a medicine is also a decision that deserves respectful discussion.
Take these questions to your appointment
- What is my absolute expected benefit?
- Which risks and monitoring apply to the proposed medicine?
Sources & review
This is original educational content based on the sources below, not reproduced textbook material. Website supervisor: Dr. Nizar Ismail. Individual medical review of this article is pending.
This information cannot replace diagnosis or a personal treatment plan. Consult your care team about symptoms or decisions about your treatment.